Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.57 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.57 |
| ▸ | GAPDH | P04406 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 2/20 | 0.50 |
| ▸ | GPR132 | Q9UNW8 | 1/20 | 0.50 |
| ▸ | LTB4R2 | Q9NPC1 | 2/20 | 0.47 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | BACE1 | P56817 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.44 |
| ▸ | CETP | P11597 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5677791 | 1.00 | MAPT (0.57) | MAPTTRPA1DDAH1GAPDHPPARG | |
| SCHEMBL11857531 | 0.98 | MAPT (0.55) | MAPTTRPA1DDAH1GAPDHPPARG | |
| SCHEMBL11857537 | 0.98 | MAPT (0.55) | MAPTTRPA1DDAH1GAPDHPPARG | |
| SCHEMBL11200210 | 0.93 | ACHE (0.53) | MAPTTRPA1DDAH1GAPDHPPARG | |
| SCHEMBL11200212 | 0.93 | ACHE (0.53) | MAPTTRPA1DDAH1GAPDHPPARG | |
| SCHEMBL29169716 | 0.91 | PPARG (0.58) | MAPTTRPA1DDAH1GAPDHPPARG | |
| SCHEMBL11855470 | 0.89 | PPARG (0.61) | MAPTTRPA1DDAH1GAPDHPPARG | |
| SCHEMBL812291 | 0.89 | PPARG (0.61) | MAPTTRPA1DDAH1GAPDHPPARG | |
| SCHEMBL2264995 | 0.89 | PPARG (0.61) | MAPTTRPA1DDAH1GAPDHPPARG | |
| SCHEMBL9648002 | 0.89 | PPARG (0.61) | MAPTTRPA1DDAH1GAPDHPPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11479739-B2 | Cyclic oxy ether compounds as perfuming ingredients | FIRMENICH SA (CH) | 2022-10-25 | — | — | US | disclosed |
| EP-4022017-A1 | COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF RAW MATERIAL MALODOURS IN SOAP BASES | Firmenich SA (CH) | 2022-07-06 | — | — | EP | disclosed |
| CN-114401974-A | Process for preparing alkoxy-functional organosilicon compounds | 美国陶氏有机硅公司 | 2022-04-26 | — | — | CN | disclosed |
| CN-114375314-A | Process for preparing alkoxy-functional organosiloxane compounds | 美国陶氏有机硅公司 | 2022-04-19 | — | — | CN | disclosed |
| WO-2021122045-A1 | COMPOSITIONS TO LIMIT OR ELIMINATE PERCEPTION OF RAW MATERIAL MALODOURS IN SOAP BASES | FIRMENICH SA (CH) | 2021-06-24 | — | — | WO | disclosed |
| EP-3749281-A1 | PERFUME COMPLEX AND SCENTED WATER COMPOSITION | Expressions Parfumees (FR) | 2020-12-16 | — | — | EP | disclosed |
| WO-2019154892-A1 | PERFUME COMPLEX AND SCENTED WATER COMPOSITION | EXPRESSIONS PARFUMÉES (FR) | 2019-08-15 | — | — | WO | disclosed |
| EP-1631247-A1 | 2-METHYL-5-PHENYLPENTANAL USED AS ROSE ODORIFEROUS SUBSTANCE | Symrise GmbH & Co. KG (DE) | 2006-03-08 | — | — | EP | disclosed |
| WO-2004105724-A1 | 2-METHYL-5-PHENYLPENTANAL USED AS ROSE ODORIFEROUS SUBSTANCE | SYMRISE GMBH & CO. KG (DE) | 2004-12-09 | — | — | WO | disclosed |
| US-4948781-A | ETHERS AND MIXED ACETALS | GIVAUDAN CORPORATION (US) | 1990-08-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11479739-B2 | Cyclic oxy ether compounds as perfuming ingredients | CBR3, CYP2E1, CBR1 | MAPT 3811/4885TRPA1 435/4885DDAH1 2742/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.